These results may indicate a positive correlation between serum prohepcidin and serum hepcidin levels in patients with chronic hepatitis C. By contrast, there was a negative correlation between serum prohepcidin and serum hepcidin levels in patients with inflammatory bowel disease (IBD) by univariate analysis (31). Here, HAMP is linked to chronic hepatitis C virus infection.